Addus HomeCare (NASDAQ:ADUS) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a research report report published on Monday.

Other equities research analysts have also recently issued research reports about the company. William Blair restated an outperform rating on shares of Addus HomeCare in a report on Monday, February 5th. Bank of America lifted their target price on Addus HomeCare from $115.00 to $118.00 and gave the company a buy rating in a report on Tuesday, May 7th. Oppenheimer reiterated an outperform rating and issued a $118.00 target price on shares of Addus HomeCare in a report on Tuesday, March 26th. Stephens reiterated an overweight rating and issued a $115.00 target price on shares of Addus HomeCare in a report on Tuesday, May 7th. Finally, TD Cowen lifted their target price on Addus HomeCare from $105.00 to $119.00 and gave the company a buy rating in a report on Thursday, May 9th. One equities research analyst has rated the stock with a sell rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has an average rating of Moderate Buy and an average target price of $108.57.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $109.04 on Monday. The business’s fifty day moving average price is $101.68 and its two-hundred day moving average price is $94.80. The stock has a market cap of $1.78 billion, a PE ratio of 27.06, a price-to-earnings-growth ratio of 2.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. Addus HomeCare has a one year low of $78.35 and a one year high of $111.99.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter last year, the firm earned $0.84 earnings per share. The business’s revenue was up 11.6% on a year-over-year basis. On average, analysts forecast that Addus HomeCare will post 4.4 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in ADUS. Principal Securities Inc. purchased a new position in Addus HomeCare in the fourth quarter valued at about $26,000. GAMMA Investing LLC purchased a new stake in shares of Addus HomeCare during the fourth quarter worth about $34,000. EntryPoint Capital LLC purchased a new stake in shares of Addus HomeCare during the first quarter worth about $44,000. Assetmark Inc. increased its position in shares of Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Addus HomeCare during the third quarter worth about $189,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.